Latest Colistin Stories
Funding to Support Development of New Treatments for Drug-Resistant Gram-Negative Bacterial Infections OKLAHOMA CITY, Sept. 16, 2014 /PRNewswire/ -- Synereca Pharmaceutics, Inc.
PARSIPPANY, N.J., July 5, 2011 /PRNewswire/ -- JHP Pharmaceuticals, a leading marketer and manufacturer of sterile injectable products, is launching larger pack sizes for three products commonly used in acute care clinical settings: AdrenalinÂ® (epinephrine injection, USP), Coly-MycinÂ® M Parenteral (colistimethate sodium, USP) and PitocinÂ® (oxytocin injection, USP synthetic). Stuart Hinchen, CEO and President of JHP noted, "The larger pack size was developed to meet customer demand...
An antibacterial peptide shows promise as an effective therapy against infections in burn or blast wounds suffered by soldiers.
An antibacterial peptide developed by Laszlo Otvos, a research professor of biology in Temple's College of Science and Technology, looks to be a highly-effective therapy against infections in burn or blast wounds suffered by soldiers.
- Company receives clearance to add voriconazole to its YeastOne(R) susceptibility plate for in vitro diagnostics; plate now includes four FDA-cleared antifungal agents - New Research-Use-Only Sensititre(R) Xtra Gram Negative MIC Plate incorporates 21 antimicrobics, including colistin and polymixin B CLEVELAND, May 14 /PRNewswire/ -- TREK Diagnostic Systems, a Magellan Biosciences company and premier provider of diagnostic systems and susceptibility products for microbiology labs, will...
Soldiers who survive severe injuries in Iraq and Afghanistan can be at risk of developing infections in their wounds, U.S. researchers say. Dr. Clinton K.
Soldiers who survive severe injuries on battlefields such as those in Iraq and Afghanistan can be at risk from developing infections of their wounds with multidrug resistant bacteria.
Infection now widespread among soldiers wounded in Iraq and Afghanistan.
HELSINKI, October 28 /PRNewswire/ -- Northern Antibiotics Ltd., the developer of novel polymyxin derivatives for the treatment of infections caused by multidrug-resistant Gram-negative bacteria, revealed today animal efficacy and pharmacokinetic data from their NAB compounds at the 48th Annual ICAAC/IDSA 46th Annual Meeting in Washington, DC.
Burkholderia pseudomallei is a Gram-negative, bipolar, aerobic, motile rod-shaped bacterium. It causes the disease melioidosis in humans and animals and is also capable of infecting plants. The bacteria can from in a number of artificial environments. Optimal temperature is around 40Â°C in pH-neutral or slightly acidic environments. Most strains can ferment sugars without gas formation. The bacteria produces both exo and endo toxins although the role of these toxins has not been fully...
- A serpent whose bite was fabled to produce intense thirst.